Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Hyperfine, Inc. - Class A Common Stock (NQ: HYPR ) 1.090 +0.040 (+3.81%) Streaming Delayed Price Updated: 10:08 AM EDT, Aug 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 12,634 Open 1.040 Bid (Size) 1.070 (1) Ask (Size) 1.100 (1) Prev. Close 1.050 Today's Range 1.040 - 1.090 52wk Range 0.7613 - 2.780 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News HYPR Stock Earnings: Hyperfine Meets EPS, Beats Revenue for Q2 2024 August 08, 2024 HYPR stock results show that Hyperfine met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. Via InvestorPlace Hyperfine, Inc. Reports Record Quarterly Revenue and Raises FY 2024 Revenue Guidance August 08, 2024 From Hyperfine, Inc. Via GlobeNewswire Performance YTD -3.54% -3.54% 1 Month +2.83% +2.83% 3 Month +25.29% +25.29% 6 Month +1.87% +1.87% 1 Year -52.61% -52.61% More News Read More Hyperfine Announces Presentation of Initial Data from Observational Clinical Studies Evaluating the Use of Portable MR Brain Imaging for Alzheimer's Patients July 30, 2024 From Hyperfine, Inc. Via Business Wire Hyperfine Announces FDA Clearance of Software Update That Enables Faster Acquisition of Best-in-Class Ultra-Low-Field Brain Images July 17, 2024 From Hyperfine, Inc. Via Business Wire Recap: Hyperfine Q4 Earnings March 21, 2024 Via Benzinga Hyperfine Earnings Preview March 20, 2024 Via Benzinga Portable MRI as a Tissue Clock for Acute Ischemic Stroke: Multi-Site Study to be Published in August 2024 Edition of Annals of Neurology Shows the Value of the Ultra-Low-Field Swoop® Portable MR Imaging® System in Acute Stroke Diagnosis July 15, 2024 From Hyperfine, Inc. Via Business Wire Hyperfine, Inc. to Announce Second Quarter 2024 Financial Results on August 8, 2024 July 11, 2024 From Hyperfine, Inc. Via Business Wire Hyperfine Expands European Market Reach with Additional Strategic Distributor Partners July 10, 2024 From Hyperfine, Inc. Via Business Wire Clinical Research Using Swoop® System for Alzheimer's Disease Monitoring to be Presented at the 2024 Alzheimer’s Association International Conference June 25, 2024 From Hyperfine, Inc. Via Business Wire Hyperfine, Inc. to Host Analyst and Investor Education Webcast with Clinical and Brain Imaging Experts on June 25, 2024 June 03, 2024 From Hyperfine, Inc. Via Business Wire Hyperfine, Inc. Continues Global Market Expansion by Entering Into a Distribution Partnership with Radiosurgery Global, Ltd. to Bring the Swoop® System to India May 28, 2024 From Hyperfine, Inc. Via Business Wire The Dollar Menu Portfolio: 7 Penny Stocks to Buy With Spare Change May 24, 2024 Via InvestorPlace Hyperfine, Inc. to Present at the Jefferies Global Healthcare Conference May 22, 2024 From Hyperfine, Inc. Via Business Wire Hyperfine, Inc. Celebrates ASNR 2024 May 22, 2024 From Hyperfine, Inc. Via Business Wire HYPR Stock Earnings: Hyperfine Beats EPS, Beats Revenue for Q1 2024 May 13, 2024 Via InvestorPlace Hyperfine, Inc. Reports First Quarter 2024 Financial Results May 13, 2024 From Hyperfine, Inc. Via GlobeNewswire Hyperfine, Inc. to Expand Global Market Reach with Appointment of International Distributors in Key European Markets May 10, 2024 From Hyperfine, Inc. Via Business Wire Hyperfine, Inc. to Announce First Quarter 2024 Financial Results on May 13, 2024 April 29, 2024 From Hyperfine, Inc. Via Business Wire Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions April 23, 2024 From Hyperfine, Inc. Via Business Wire Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study April 17, 2024 From Hyperfine, Inc. Via Business Wire HYPR Stock Earnings: Hyperfine Beats EPS, Misses Revenue for Q4 2023 March 21, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session March 21, 2024 Via Benzinga Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results March 21, 2024 From Hyperfine, Inc. Via GlobeNewswire Earnings Scheduled For March 21, 2024 March 21, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
